siRNAs used in this study
| siRNA | Sequence (sense) | Concen. |
| nM | ||
| si-control | 30 | |
| si-fascin-1 | 5′-CAAAGACUCCACAGGCAAAUU-3′ | 30 |
| si-fascin-2 | 5′-GAGCAUGGCUUCAUCGGCU-3′ | 30 |
| si–T-fimbrin–1 | 5′-GAAAGAACCUUCCGUAACU-3′ | 30 |
| si–T-fimbrin–2 | 5′-CTGAAAAUUUGCCGAAGUA-3′ | 30 |
| si-myosinX-1 | 5′-CGUCGUAGCUGAUGUCUUA-3′ | 10 |
| si-myosinX-2 | 5′-GGAGGAAAUUUCAGGGAAU-3′ | 10 |
| si-p34 | 5′-CCAUGUAUGUUGAGUCUAA-3′ | 10 |
| 5′-GCUCUAAGGCCUAUAUUCA-3′ | ||
| 5′-GGACAGAGUCACAGUAGUC-3′ | ||
| 5′-GUACGGGAGUUUCUUGGUA-3′ | ||
| si-mDia2-1 | 5′-GAUGACAGAUGUGGUUAAA-3′ | 30 |
| si-mDia2-2 | 5′-GAGUGUGUAUCCCAGAUUG-3′ | 30 |
| si-vimentin-1 | 5′-GAGGGAAACUAAUCUGGAU-3′ | 2× 20 |
| si-vimentin-2 | 5′-GGAAAUGGCUCGUCACCUU-3′ |
| siRNA | Sequence (sense) | Concen. |
| nM | ||
| si-control | 30 | |
| si-fascin-1 | 5′-CAAAGACUCCACAGGCAAAUU-3′ | 30 |
| si-fascin-2 | 5′-GAGCAUGGCUUCAUCGGCU-3′ | 30 |
| si–T-fimbrin–1 | 5′-GAAAGAACCUUCCGUAACU-3′ | 30 |
| si–T-fimbrin–2 | 5′-CTGAAAAUUUGCCGAAGUA-3′ | 30 |
| si-myosinX-1 | 5′-CGUCGUAGCUGAUGUCUUA-3′ | 10 |
| si-myosinX-2 | 5′-GGAGGAAAUUUCAGGGAAU-3′ | 10 |
| si-p34 | 5′-CCAUGUAUGUUGAGUCUAA-3′ | 10 |
| 5′-GCUCUAAGGCCUAUAUUCA-3′ | ||
| 5′-GGACAGAGUCACAGUAGUC-3′ | ||
| 5′-GUACGGGAGUUUCUUGGUA-3′ | ||
| si-mDia2-1 | 5′-GAUGACAGAUGUGGUUAAA-3′ | 30 |
| si-mDia2-2 | 5′-GAGUGUGUAUCCCAGAUUG-3′ | 30 |
| si-vimentin-1 | 5′-GAGGGAAACUAAUCUGGAU-3′ | 2× 20 |
| si-vimentin-2 | 5′-GGAAAUGGCUCGUCACCUU-3′ |
Concen., concentration. Thermo Fisher Scientific did not provide the sequence of si-control.